ABSTRACT
Objective To investigate the characteristics and risk factors of pulmonary hypertension (PH) in patients with chronic obstructive pulmonary disease (COPD) in plateau areas. Methods To select 562 COPD patients in Qinghai Plateau from January 2017 to December 2020 in the Qinghai Province Cardiovascular and Cerebrovascular Disease Specialist Hospital. The patients were divided according to pulmonary artery systolic pressure (PASP) pulmonary hypertension (PH) group (PASP≥40mmHg) and non-pulmonary hypertension (NPH) group (PASP2=30.848, P＜0.001). The percentage of forced expiratory volume in one second (FEV1%), blood oxygen saturation, B-type natriuretic peptide, mean platelet volume (MPV) in the PH group were different from those of NPH group (P<0.05). Multivariate logistic regression analysis showed that FEV1% [OR=1.082 (95%CI: 1.038-1.256)], MPV [OR=1.696 (95%CI: 1.273-2.257)] were risk factors for COPD patients with PH in high altitude areas (P<0.05). Conclusion The incidence of PH is higher in COPD patients in plateau areas, and COPD patients with lower FEV1% and higher MPV are more likely to develop PH.
ABSTRACT
Bacterial biofilm refers to a tunicate-like biological group composed of polysaccharide, protein and nucleic acid secreted by bacteria on the surface of the mucous membrane or biological material. The biofilm formation is a major cause of chronic infections. Bacteria could produce some secondary metabolites during the growth and reproduction. Some of them act as signaling molecules allowing bacteria to communicate and regulate many important physiological behaviors at multiple-cell level, such as bioluminescence, biofilm formation, motility and lifestyles. Usually, these signal molecules play an important role in the formation of bacterial biofilm. We review here the effects of related signal molecules of Quorum Sensing, cyclic diguanylate, Two-Component Systems and sRNA on the biofilm formation. Focusing on these regulation mechanism of signal molecules in the process of biofilm formation is necessary for the prevention and treatment of some chronic diseases.
Subject(s)
Bacterial Proteins , Biofilms , Cyclic GMP , Gene Expression Regulation, Bacterial , Protein Binding , Quorum SensingABSTRACT
Tissue distribution of marbofloxacin was studied in pigs after a single intramuscular injection at 2.5 mg/kg body weight. Samples of plasma, muscle, liver, kidney, heart, lung, and muscle at the injection site were randomly collected from five pigs at 2, 6, 10, 24, 48, 72, and 96 h after administration. Marbofloxacin concentrations were determined by using high-performance liquid chromatography with ultraviolet detection and were subjected to non-compartmental analysis to obtain kinetic parameters. The elimination half-life (t(1/2λz)) of marbofloxacin at the injection site was 22.12 h, while those in kidney, plasma, liver, lung, heart, and muscle were 16.75, 21.48, 21.84, 24.00, 24.45, and 28.91 h, respectively. Areas under the concentration-time curve from 0 h to (∞) (AUC(0–∞)s) were calculated to be 31.17 h·µg·mL⁻¹ for plasma and 32.97, 33.92, 34.78, 37.58, 42.02, and 98.80 h·µg·g⁻¹ for heart, muscle, lung, liver, kidney, and injection site, respectively. The peak concentration (C(max)) of marbofloxacin was 1.62 µg/mL in plasma and 1.71, 1.74, 1.86, 1.93, 2.45, and 7.64 µg/g in heart, lung, muscle, kidney, liver, and injection site, respectively. The results show that marbofloxacin was fast absorbed, extensively distributed, and slowly eliminated from pigs after a single intramuscular administration.